In this paper, we review literature updates and summarize the current knowledge about the opposing role of the CX3CL1/CX3CR1 signaling pathway in selected neuropathologies (including ischemia, epilepsy, and neurodegenerative diseases). Here, CX3CL1 is linked to epilepsy.